# Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

> **NCT00511433** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 48 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** NOMAC-E2
- **DRUG:** DRSP-EE

## Key facts

- **NCT ID:** NCT00511433
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511433, "Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00511433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*